Transcardiac Therapeutics, Inc.
Country not established
- Devices
- 1
What Transcardiac Therapeutics, Inc. makes
Transcardiac Therapeutics, Inc. manufactures the TC ENDO PORT, a device designed for transcatheter cardiac interventions, likely used in procedures involving the heart’s electrical system or structural repair.
The TC ENDO PORT is classified as a Class II medical device under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Tc Endo Port Ref K083218
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Transcardiac Therapeutics, Inc. have in the registry?
The registry currently lists 1 device for Transcardiac Therapeutics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Transcardiac Therapeutics, Inc.'s devices?
Among its 1 most recently registered device, Transcardiac Therapeutics, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Transcardiac Therapeutics, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Transcardiac Therapeutics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Transcardiac Therapeutics, Inc. in the registry?
The most recently registered devices listed for Transcardiac Therapeutics, Inc. include TC ENDO PORT.